Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUG: Glucose for Post-lobectomy Air-leak Cessation
NCT02376218Phase 1Completed
- Start
- Apr 2015
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dextrose in air leak syndrome (ALS). Primary endpoint: Air leak cessation at 48 hours. Started Apr 2015; status: completed.
02
Drugs
dextrose
03
Conditions
air leak syndrome (ALS)
Beyond the preview
Go deeper on NCT02376218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02376218.